Finland, with its robust healthcare system and comprehensive data infrastructure, provides an ideal environment for conducting real-world evidence (RWE) studies.
In this context, let’s explore the distinctive features of Finnish real-world data (RWD) and how they can contribute towards high-impact research:
1. […]
Since 2020, Quantify Research has been a proud partner to the European Medicines Agency-coordinated ENCePP (European Network for Centres of Pharmacoepidemiology and Pharmacovigilance) initiative.
This network brings together expertise and resources in pharmacoepidemiology and pharmacovigilance across Europe with […]
Turning complex data into valuable insights is crucial. Efficient data visualizations play a key role, revealing compelling stories about historical patterns, current trends, and future opportunities.
In today’s dynamic and data-driven healthcare landscape, there is frequent demand for adaptive analysis tools […]
The Quantify team had a great first day at SHEA!
The team contributed to a theme session, an oral presentation and a poster presentation, and had the opportunity to reconnect with many familiar faces.
We are looking forward to meeting many more […]
Quantify’s Emilie Toresson Grip, Olivia Ernstsson, Johan Liseth Hansen, Konstantin Macheridis and Linnea Oldsberg are looking forward to (re)connecting with our fellow Swedish health economists […]
– Local affiliates may play an important role in the PICO simulation and scoping process : EU teams will rely on Nordic affiliates to provide local market information for PICO simulation and preparation.
Moreover, local affiliates may become an important point […]
Quantify Research Denmark is growing!
Last week we welcomed Sara Hallum Søndergaard to the team in Copenhagen.
Sara has a background in public health and epidemiology from the University of Copenhagen (Københavns Universitet). Before joining Quantify Research, […]
About a week ago, FDA approved the very first treatment for patients with liver fibrosis caused by fatty liver disease.
Rezdiffra (resmetirom) is now approved for treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), […]
We are very excited to introduce our latest recruit to the Danish team!
Morten Johnsen recently joined us following the completion of his Masters in Quantitative Biology and Disease Modelling from DTU […]